NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Jul. 21, 2015--
Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent
company of Lantheus Medical Imaging, Inc. (“LMI”), today announced that
it will host a conference call at 4:30 p.m. ET on Tuesday, August 4,
2015, to discuss its financial and operating results for the second
quarter of 2015.
To access the live conference call via telephone, please dial
1-866-498-8390 (U.S. callers) or 1-678-509-7599 (international callers)
and provide passcode 91877950. A live audio webcast of the call also
will be available on the homepage of the Company’s website at www.lantheus.com.
A replay of the telephone conference call and audio webcast will be
available from approximately 8:30 p.m. ET on August 4, 2015 through
midnight on August 18, 2015. To access a replay of the conference call,
dial 1-855-859-2056 (U.S. callers) or 1-404-537-3406 (international
callers), and provide passcode 91877950.
About Lantheus Holdings, Inc. and Lantheus Medical Imaging, Inc.
Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc.
(“LMI”), which is a global leader in developing, manufacturing, selling
and distributing innovative diagnostic imaging agents and products. LMI
provides a broad portfolio of products, which are primarily used for the
diagnosis of cardiovascular diseases. LMI’s key products include the
echocardiography contrast agent DEFINITY® Vial for
(Perflutren Lipid Microsphere) Injectable Suspension; TechneLite®
(Technetium Tc99m Generator), a technetium-based generator that provides
the essential medical isotope used in nuclear medicine procedures; and
Xenon (Xenon Xe 133 Gas), an inhaled radiopharmaceutical imaging agent
used to evaluate pulmonary function and for imaging the lungs.
The Company has more than 500 employees worldwide with headquarters in
North Billerica, Massachusetts, and offices in Puerto Rico, Canada and
Australia. For more information, visit www.lantheus.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150721006707/en/
Source: Lantheus Holdings, Inc.
For Lantheus Holdings, Inc.
Meara Murphy, 978-671-8508